跨导管大动脉置换后新的永久起器植入的预后影响

Hua-Jie Zheng1, Chao-Jun Yan1, De-Qing Lin1

  • 1Department of Cardiac Surgery, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing, China.

概括

穿透导管大动脉置换 (TAVR) 后的永久心脏起器植入 (PPI) 是常见的. 虽然不增加死亡率,但新的PPI与更高的心力衰竭再住院和较差的LVEF改善有关.